Desmopressin Acetate Tablet — Class II drug recall D-0077-2023
Terminated recall by RemedyRepack Inc., reported 2022-12-14. Subpotent Drug: repackaged product was recalled by the manufacturer for subpotency.
| Recall number | D-0077-2023 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | RemedyRepack Inc., Indiana, PA, United States |
| Recall initiated | 2022-12-05 |
| Classified | 2022-12-07 |
| Reported by FDA | 2022-12-14 |
| Terminated | 2023-02-03 |
| Quantity | 9 boxes |
| Reason classes | potency |
| NDC | 23155-0490-01, 70518-3493-00 |
| Lot numbers | B1817019-082222, B1819127-082322 |
| Expiration dates | 2023-02-24, 2023-02-26 |
Product
Desmopressin Acetate Tablet, 0.2 mg, 100-count box, Rx only, Source NDC: 23155-0490-01; MFG: Avet Pharmaceuticals Inc., East Brunswick, NJ 08816; Repackaged by: RemedyRepack Inc., Indiana, PA 15701, NDC #: 70518-3493-00.
Reason for recall
Subpotent Drug: repackaged product was recalled by the manufacturer for subpotency.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0077-2023. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.